The Bloom Newsletter

Make sense of psychedelic research

Every week, we distill the latest psychedelic science into a 5-minute read covering research papers, new trials, events, and deep dive blogs. Trusted by 3,000+ researchers, clinicians, and investors.

Trusted by professionals worldwide

Read at

AtaiBeckley
Psychedelics Today
MAPS
Johns Hopkins
Noetic Fund

Read at 50+ Universities

Imperial College London
UC Berkeley
University of Zurich
Monash University
Maastricht University

Read at Leading Companies & Investors

JLS Ventures
Compass Pathways
Lionheart Ventures
Definium Therapeutics
Helus Pharma

Read at Non-Profits, Governments & Think Tanks

Brain Futures
Usona Institute
SAMHSA
Delphi
Psychedelic Alpha

What the experts say

Blossom is democratising access to psychedelic research by presenting papers from a broad range of disciplines in an accessible weekly write-up.

Josh Hardman
Founder, Psychedelic Alpha